ReviewFoods (Basel, Switzerland)2026
Bioactive Compounds in Fruit Wines: A Narrative Review.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fruit wines produced from non-grape fruits are gaining increasing attention as value-added fermented beverages due to their diverse chemical composition and content of bioactive compounds. This narrative review provides a comparative overview of fruit wines obtained from berries, drupes, pome fruits, citrus fruits, and tropical fruits, with particular emphasis on their physicochemical characteristics, phenolic composition, antioxidant properties, and technological aspects of production. Rather than considering fruit wines as a single category, the available evidence is examined across different fruit groups to identify characteristic patterns in the occurrence and relative abundance of bioactive compounds and their associated antioxidant activity. Berry wines are generally distinguished by their high phenolic and anthocyanin contents, whereas wines produced from other fruit categories exhibit distinct profiles of phenolic acids, flavonoids, and other bioactive constituents. Differences in raw materials and technological conditions, including fermentation and processing strategies, contribute substantially to the variability observed in the composition and functional properties of the resulting wines. The review also considers fruit-wine pomace as a potentially valuable source of residual bioactive compounds, highlighting opportunities for its valorization within sustainable and circular production systems. However, differences in analytical methods, reporting units, sample matrices, and experimental conditions currently limit direct quantitative comparisons among studies. Overall, this review integrates compositional, technological, and antioxidant-activity data across major fruit categories, identifies current knowledge gaps, and highlights opportunities for improving fruit-wine production, analytical characterization, and the sustainable utilization of fruit-processing by-products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.